GRI Bio (GRI) Amortizatization of Intangibles (2020 - 2022)
GRI Bio (GRI) posted quarterly Amortizatization of Intangibles of $233000.0 for Q3 2022, up 1126.32% year-over-year from $19000.0 in Q3 2021, and up 606.52% quarter-over-quarter from -$46000.0 in Q2 2022.
GRI Bio (GRI) Amortizatization of Intangibles (2020 - 2022) Analysis & Trends
GRI Bio's Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at $233000.0 for Q3 2022.
- In Q3 2022, Amortizatization of Intangibles rose 1126.32% year-over-year to $233000.0; the TTM figure through Mar 2023 stood at $187000.0 (up 703.23% YoY), while the FY2022 annual figure was $206000.0, up 743.75% from the prior year.
- Amortizatization of Intangibles for Q3 2022 stood at $233000.0, up from -$46000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $233000.0 in Q3 2022, with the low at -$87000.0 in Q4 2021.
- The 3-year median for Amortizatization of Intangibles is $18000.0 (2020), against an average of $15818.2.
- Peak annual rise in Amortizatization of Intangibles reached 1126.32% in 2022, while the deepest fall reached 355.56% in 2022.
- GRI Bio's Amortizatization of Intangibles stood at -$55000.0 in 2020, then plunged by 58.18% to -$87000.0 in 2021, then surged by 367.82% to $233000.0 in 2022.
- Business Quant data shows GRI's Amortizatization of Intangibles at $233000.0 in Q3 2022, -$46000.0 in Q2 2022, and $19000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | GRI Bio | 3.01 Mn | 3.01 Mn | - | 14,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 233,000.00 |
| Sep 30, 2022 | 233,000.00 |
| Jun 30, 2022 | -46,000.00 |
| Jun 30, 2022 | -46,000.00 |
| Mar 31, 2022 | 19,000.00 |
| Mar 31, 2022 | 19,000.00 |
| Dec 31, 2021 | -87,000.00 |
| Dec 31, 2021 | -87,000.00 |
| Sep 30, 2021 | 19,000.00 |
| Sep 30, 2021 | 19,000.00 |
| Jun 30, 2021 | 18,000.00 |
| Jun 30, 2021 | 18,000.00 |
| Mar 31, 2021 | 18,000.00 |
| Mar 31, 2021 | 18,000.00 |
| Dec 31, 2020 | -55,000.00 |
| Dec 31, 2020 | -55,000.00 |
| Sep 30, 2020 | 18,000.00 |
| Sep 30, 2020 | 18,000.00 |
| Jun 30, 2020 | 19,000.00 |
| Jun 30, 2020 | 19,000.00 |